Welcome!

To all those reading this I am David Gibbs; I am a Lecturer in Law at the University of East Anglia.

I created this blog as a general out-let of ideas for my research, as well as keeping those interested up-to-date on my research and general interests.

I completed my PhD thesis at the University of East Anglia in 2014. The thesis was recommended for the award of PhD with no corrections. My external examiner was Prof. Simon Deakin (Cambridge) and internal examiner was Prof. Morten Hviid.
My PhD research centred on directors' duties and company law. The thesis was titled 'Non-Executive Self-Interest: Fiduciary Duties and Corporate Governance'. It was a doctrinal and empirical study on whether self-interest was suitably controlled amongst non-executive directors.

My supervisors were Prof. Mathias Siems, Prof. Duncan Sheehan, Dr. Sara Connolly and Dr. Rob Heywood

All opinions of any existing or future blogpost are my own. They do not necessarily represent the views of any of my associated institutions.
ORCID 0000-0002-6596-8536



Tuesday, 24 April 2012

What are my readers interested in?

OK, I may be turning the blogosphere in to something similar to Primark through this blogpost. But it is inspired from one of the blogs I follow, that of one of my supervisors throughout my PhD. His blog post looked at the stats of his followers, and so I aim to do the same.

So my audience are primarily from English speaking countries: (1) United Kingdom (3503); (2) United States (1295). After these two though there are perhaps surprising results with (3) Russia (457); (4) Germany (161); and (5) Malaysia (113). I would have predicted more results from countries such as Canada and Australia, but neither feature above 50.

So what posts are people interested? Well primarily it appears to be areas of European Company Law or perhaps more accurately the regulation of company law in Europe. Both my articles on the conference on European Company Law have received 352 and 262 views respectively. My post on the Companies Act section 175 makes up the top three posts with 203 views. This may predominately be due to its feature on the Lexis Nexis Community.

Looking at the page views after the last month it is unsurprising to see my recent, more substantial post, on outside directors at the top. However, this is joined by my most popular post on the conference on European Company Law both receiving 34 views in the last month. Based on my own observations on tracking I have noticed some other posts "trending" as it were. My post on derivative claims has received 20 views this month; whilst my posts on how to cite Hydrodan Corby has received 23 and my post on Christmas procrastination has received 33. The latter evidencing people's love for cartoons and procrastination? This post in total has received 126 views since it was first posted.

Dividing the total amount of views by the amount of months since they were posted my top five blog posts would appear in the following order: (1) Conference on European Company Law Stream 1 analysis (32); (2) Conference on European Company Law and employee participation in the SE (23.82); (3) Queen's Bench consider section 175 (13.53); (4) Christmas Procrastination (31.5); and (5) Hydrodan Corby v Hydrodam Corby (13.29). So views per month published Christmas Procrastination jumps to the second most popular with the others all moving down one accordingly except for the European Company Law post staying put at 1.

So what I conclude from this is people seem to be interested in European Company Law and cartoons. The popularity of my post on the case of Hydrodan/Hydrodam also evidences that I was not the only one confused as to how it should be cited and spelt. Perhaps most importantly of all my blog appears as the 10th search result for the phrase "European Company Law". Typing in my own name my blog now appears as the 3rd result. I see this as some sort of achievement as I remember searching before I established this blog and I certainly did not even appear on the first page.

Monday, 23 April 2012

IGLRC 2012

Last week I presented my research at the International Graduate Legal Research Conference 2012 at King's College London. My panel was chaired by Dr Michael Schillig.

The event itself was well organised, engaging and interesting. I was able to meet a number of academics and research students in a variety of fields. I also attended the plenary session given by Professor David Kennedy from Harvard in the evening.

I attended a number of other talks from other research students, but this being my first significant external presentation I felt I gained most by presenting rather than listening.

It was interesting in some cases to note the differences in presentations based on the level of study people where at. Certainly students only just setting out on their PhDs mainly discussed the area they were looking in to and aimed to highlight the problems, whereas people further along where able to evidence firm conclusions or talk about more specific points. This of course was of no gauge as to the quality of the presentations, all of which I found thoroughly engaging although not always in my area.

For an outline of what I discussed in my presentation, please see my previous blog post. If you are interested in reading my paper or looking at my presentation, please do get in touch. I am considering uploading it, or something similar, to SSRN in the near future. I do not plan to do it now since I developed my presentation a bit after completing my paper as I had been able to conduct further empirical analysis.



Wednesday, 11 April 2012

How do you control outside directors?

The law and regulation of non-executive directors or outside directors has remained elusive. In the UK little is known about their duties and their role can vary.

In the UK the case of The Equitable Life Assurance Society v Bowley [2003] EWHC 2263 opined that non-executives owe the same duties as executives. However, in recognition of their different roles the application of those duties will be different. Bowley concerned section 174 in regard to a director's duty to act with reasonable skill care and diligence. Applying a different application here can be relatively simple. For example in Continental Assurance Co of London plc, Re [1996] BCC 888 the judge recognised that non-executives were expected to have awareness of general accounting standards but not be experts.

But what of the other duties? How would a judge differ in his/her application of say a breach of s176 to not accept benefits from a third party; or s175 to avoid a conflict of interest?

The case of Cambridge v Makin [2011] EWHC 12 (QB) dealt with, albeit in obiter, with the latter duty. Here the judge noted that the meaning of what an "interest" is was not clear, and it was also not clear whether a non-executive was prohibited from competing with the company.

Now the standard of section 175 is very rigid. In its application to executives it is seen that the court will have no consideration as to whether the director acted in good faith, whether the company could actually take the opportunity, they pursued the opportunity in their own time, or the opportunity was not within the company's scope of business. For non-executives, one cannot simply apply the executive standard. As mentioned above, that standard applies to opportunities that fall outside the company's scope of business. This may serve as a severe restriction on non-executives who often hold more than one appointment. If the executive standard is applied, if they gave the opportunity to one principal they realistically could be sued by the other principal.

Determining whether an individual owes fiduciary duties depends on the relationship the parties have. Edelman (2010) 126 LQR 302 submits that they will arise when an individual undertakes a voluntary obligation where a principal will have a reasonable expectation to protection. However, those duties will not be the same in all cases as their extent will depend on the exact nature of the relationship. This is why there is a different application of the fiduciary duties, now imposed by law under part 10, for executives and non-executives. The executive role is much more intimate with the company, which explains the higher standard.

So to determine the extent a non-executive owes a duty to avoid a conflict of interest may come down to intimacy of the relationship with the company. The role of the non-executive has continually developed over the past 20 years since the publication of the Cadbury Report on Corporate Governance in 1992. Their role, although part time, is one of supervision, challenge and strategy. Whilst twenty years ago you may have had a stronger argument to say non-executives do not owe a duty to avoid a conflict of interest, or a very low standard, it is unlikely that still holds true.

The case of Aas v Benham [1891] 2 Ch 244 however demonstrates that the conflict duty can be altered in some respects. This case concerned a partnership rather than directors. Here the partner was excused from a conflict because it fell outside the company's scope of business. The Court of Appeal recently rejected a scope of business test for executive directors in Allied Business & Financial Consultants Ltd, Re [2009] EWCA Civ 751 based on the differences in the relationship between partners and executive directors, but it is plausible a scope of business test can still be applied to non-executives.

From this one problem would remain. What exactly is a scope of business test? When Aas v Benham was decided the ultra vires rule was still in effect to restrain directors from acting outside the company's objects to protect the shareholders and creditors. Thus, a company could not act outside what it had set out to do in its constitution.

Now the ultra vires rule has been replaced due to its unreasonable restrictions on business activity and has been replaced by the fiduciary duties. Now a company is effectively allowed to do anything legal.

So interpreting a scope of business test could be wide or narrow. Do we assess it on what the company actually does? or what it has the potential to do? This may ultimately be fact sensitive though. The court may apply a wider test for a non-executive with a more intimate relationship than a non-executive who is less involved. Such an approach can be infered from the case of Langreen Ltd, Re (unreported) 21st Oct 2011 where the court found that whilst the individuals where called non-executives, they were in fact executives and held to that standard.

So, non-executives may be controlled from acting against his principal's interests via fiduciary duties. However, is this enough? Fiduciary duties are rarely enforced. There may also be unexpected legal problems with any claim since the law is not clearly tested. For example, giving an opportunity to a different principal the director personally may have no profit to disgorge which is the usual remedy. Thus the company may only have a claim for compensation which would require the company to show a causal link between the non-executives actions and the company's loss. This was seen in the case of Item Software (UK) Ltd v Fassihi [2004] EWCA Civ 1244.

Executives, unlike non-executives, receive a complex web of compensation for their role to ensure they remain incentivised. They receive long term performance plans which outweigh significantly any remuneration they receive upfront. This is largely based on agency theory which argues that a director values £1 in the hand more than a promise of £1 in the future. However, as Fama (1980) 88(2) Journal of Political Economy 288 has stated, if you simply pay everything upfront what is to stop an individual consuming more perquisites to the detriment of the company after receiving his remuneration? The result is the mix of ex ante and ex post rewards for the executive to ensure they remain incentivised to prefer the interests of the company over their own.

Non-executives do not have these compensation packages though. In the majority of cases they merely receive a fee for their services and hold a small equitable interest in the company (mean 2010: .041%; median 2010: .008% for independent non-executives)

Applying agency theory to non-executives, what is to stop non-executives assuming more perquisites to the detriment of the company after receiving their fees if they have no long term incentive plans. However, one should not simply jump to the conclusion that non-executives should receive more equity in the company and be paid through long term plans. Non-executives need to be independent. They primarily are meant to monitor the management. To incentivise them too strongly will create a stronger interest in the company, which would bring their independence in to question.

But without controls, non-executives may view additional appointments as a form of perquisite consumption and may continue to accept appointments, and stretch themselves too far to the detriment of the firms who appoint him/her. This may become more of a problem as non-executive fees continually increase to reflect their increased involvement in companies. The mean fees paid to non-executives in 2006 was £817366.67 but by 2010 that figure has risen to £1053295.67. The median is not quite as extreme but still shows an increase from £696500.00 in 2006 to £849500.00 in 2010.

Measuring non-executive additional appointments against external appointments there appears to be a significant relationship.


The correlation is significant at the .01 level with Pearson's Correlation at .513** 

Thus there may be a strong case for introducing restrictions on non-executive appointments since incentive plans are not a reasonable alternative. Some other EU states have restrictions such as Germany which only permits 10 (The German Stock Corporation Act section 100) additional appointments and in France it is 5 (The French Recommendation of Corporate Governance 2011 Part II Para D.2). Anecdotal evidence suggests non-executives or outside directors in the EU accept more appointments than in the UK. Thus a restriction of 10 may be meaningless. It is submitted that a restriction set at no more than 4 or 5 to be more appropriate.